Cancer Care Specialists of Illinois

What Cancer Care Specialists of Illinois does

Cancer Care Specialists of Illinois (CCSI) is a private, multi-specialty physician group practice headquartered in Decatur, Illinois, delivering comprehensive hematology, medical oncology, and radiation oncology services across 22+ treatment centers and clinics spanning Central and Southern Illinois and the St. Louis Metro East region. The practice was founded in 1985 by James L. Wade III, MD, and rebranded from Cancer Care Specialists of Central Illinois in December 2015 to reflect its broader geographic footprint. CCSI employs approximately 20 board-certified physicians alongside nurse practitioners and support staff, and has grown to become the largest interdisciplinary oncology-hematology practice in Illinois outside of Chicago.

The organization's service portfolio is anchored by medical oncology, hematology, and radiation oncology, supplemented by diagnostic imaging (PET/CT with PYLARIFY for prostate cancer, CT, DEXA bone densitometry), infusion services, on-site laboratory services, retail specialty pharmacy, pain management, counseling, and cancer prevention/detection programs. The CREATE (Cancer Research and Therapies of Excellence) research program provides patient access to National Cancer Institute-sponsored clinical trials through affiliations with SWOG, ECOG-ACRIN, NRG Oncology, Alliance for Clinical Trials in Oncology, Heartland Cancer Research NCORP, University of Chicago Medicine, and others. Patient engagement is supported by the Epic-based MyChart portal available on web, iOS, and Android.

CCSI generates revenue primarily through insurance reimbursements (Medicare, Medicaid, private payors) and direct patient payments for professional services rendered across its clinical network. The practice participates in the CMS Oncology Care Model, a value-based care arrangement under which CCSI has reportedly reduced cancer drug spend by 13.5% relative to other OCM participants. Distribution is executed through a hub-and-spoke model combining CCSI-owned centers (Decatur, O'Fallon, Crossroads/Effingham) with embedded specialty clinics in 15+ partner community hospitals (HSHS system hospitals, Sarah Bush Lincoln, Decatur Memorial, Carle Richland, Sparta Community, and others). Patient acquisition occurs through physician referrals, hospital partner referrals, and direct self-referrals.

Name

Cancer Care Specialists of Illinois

Legal name

Cancer Care Specialists of Illinois

Website

https://cancercarespecialists.org

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

251–500 employees

Short description

Cancer Care Specialists of Illinois is a private multi-specialty physician practice providing medical oncology, hematology, radiation oncology, imaging, infusion, and clinical trial services across 22+ locations in Central and Southern Illinois and St. Louis Metro East.

Ownership category

akta.pro rank

Product category

Community Oncology and Hematology Care

NAICS

Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

• Oncology hematology services
• Radiation oncology treatment
• Cancer clinical trials
• Medical infusion services
• Diagnostic cancer imaging

Headquarters

HQ city

Decatur

HQ country

United States

HQ region

North America

Offices22 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Patient Care Services: Cancer Care Specialists of Illinois generates revenue through the provision of medical oncology, hematology, radiation oncology, and related healthcare services to patients. Revenue is derived from insurance reimbursements (Medicare, Medicaid, private insurance) and direct patient payments for consultations, treatments, imaging, laboratory, infusion, and pharmacy services. The practice participates in the CMS Oncology Care Model for value-based care.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels10 records

Core offering

Cancer Care Specialists of Illinois is a multi-specialty physician group practice delivering comprehensive medical oncology, hematology, and radiation oncology services, supported by diagnostic imaging, infusion, laboratory, specialty pharmacy, pain management, counseling, and NCI-affiliated clinical trials through the CREATE program across 22+ treatment centers in Illinois and St. Louis Metro East.

Product overview

Cancer Care Specialists of Illinois is a multi-specialty oncology practice offering comprehensive cancer care services through 22+ locations across Central and Southern Illinois and St. Louis Metro East. The organization provides a unified portfolio of medical oncology, hematology, and radiation oncology as core services, supported by diagnostic imaging (PET/CT, CT, DEXA scans), infusion services, laboratory services, and specialty pharmacy. Their research division (CREATE – Cancer Research and Therapies of Excellence) offers clinical trials access through NCI-affiliated partnerships. Additional services include pain management, counseling, patient education, and a retail pharmacy. The MyChart patient portal provides digital access to medical records and communication tools.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Oncology & Hematology Comprehensive medical oncology and hematology services for the diagnosis, treatment, and management of cancer and blood disorders, delivered by board-certified oncologists across CCSI's 22+ locations.
• Radiation Oncology Advanced radiation oncology treatment services using state-of-the-art equipment and modern treatment methods for cancer patients across CCSI's network.
• Research & Clinical Trials (CREATE - Cancer Research and Therapies of Excellence) Clinical research program providing CCSI patients access to advanced NCI-sponsored cancer treatment and prevention trials through affiliations with SWOG, ECOG-ACRIN, NRG Oncology, Alliance for Clinical Trials in Oncology, University of Rochester Cancer Center, Wake Forest University Cancer Center, and the University of Chicago Medicine clinically integrated network.
• Imaging Services Advanced diagnostic imaging including PET/CT with FDG Prep, PET/CT with Detectnet Prep, PET/CT with PYLARIFY (piflufolastat F 18) Prep for prostate cancer imaging, CT Scan, and Bone Densitometry (DEXA) for cancer staging, treatment planning, and osteoporosis assessment.
• Infusion Services Outpatient infusion suite services administering chemotherapy, immunotherapy, hormone therapy, and targeted therapy to cancer patients at CCSI clinic locations.
• Laboratory Services On-site laboratory testing and analysis services supporting cancer diagnosis, treatment monitoring, and ongoing patient care, accredited by COLA.
• Pain Management Specialized pain management services designed for oncology patients to address cancer-related pain and improve quality of life during and after treatment.
• Retail Pharmacy On-site URAC-accredited specialty retail pharmacy providing oral oncology medications and supportive drugs directly to CCSI patients as part of integrated care.
• Counseling Psychological and emotional counseling services for cancer patients and their families to address the mental and emotional aspects of cancer diagnosis and treatment.
• Cancer Prevention & Detection Cancer screening, early detection, and prevention programs offered to community members to identify cancer risks and detect cancers at earlier, more treatable stages.
• Patient & Family Education Educational resources and programs for patients and families on cancer care, treatment options, clinical trials, and supportive care services delivered by CCSI physicians.
• MyChart Patient Portal Epic-based online patient portal and mobile app enabling patients to access medical records, view test results, manage appointments, send secure messages to physicians, and review health summaries.

Quantifiable outcome

• Reduced cancer drug spend by 13.5% relative to other practices participating in the Oncology Care Model, through value-based oncology pathways combined with performance analytics.
• +2 more outcomes

Named customers15 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core and minor.

• University of Chicago MedicinecoreStrategic or Co-development PartnerNew partnership making CCSI the newest affiliate of University of Chicago Medicine's clinically integrated network. The agreement gives CCSI's patients expedited access to the academic medical center's world-class cancer specialists, improving access, value, and quality of care.
• SWOG (formerly Southwest Oncology Group)coreStrategic or Co-development PartnerNCI-sponsored national cancer research cooperative group. CCSI physicians and staff participate in SWOG clinical trials as part of the CREATE program.
• ECOG-ACRIN Cancer Research GroupcoreStrategic or Co-development PartnerNCI-sponsored cancer research cooperative group. CCSI participates in ECOG-ACRIN clinical trials for cancer treatment and prevention research.
• NRG OncologycoreStrategic or Co-development PartnerNCI-sponsored national cancer research organization formed from the merger of NSABP, RTOG, and GOG. CCSI participates in NRG clinical trials.
• Heartland Cancer Research NCORPcoreStrategic or Co-development PartnerNCI Community Oncology Research Program (NCORP). Dr. James L. Wade III serves as principal investigator. Received $2,520,862/year for 5 years from NCI to support research staff working alongside CCSI physicians and oncology nurses.
• Alliance for Clinical Trials in OncologycoreStrategic or Co-development PartnerNCI-sponsored clinical trials research organization. CCSI participates in Alliance clinical trials for cancer research.
• University of Rochester Cancer CentercoreStrategic or Co-development PartnerNCI-designated research center. CCSI is affiliated with University of Rochester Cancer Center for NCI-sponsored research collaboration.
• Wake Forest University Cancer CentercoreStrategic or Co-development PartnerAcademic cancer center. CCSI is affiliated with Wake Forest University Cancer Center for NCI-sponsored cancer research.
• Decatur Memorial HospitalcoreStrategic or Co-development PartnerLong-standing partnership with DMH Cancer Care Institute. CCSI physicians provide oncology services and jointly host community events including National Cancer Survivors Day. DMH Cancer Care Institute collaboration enabled the 2011 ASCO Conquer Cancer Foundation Grant.
• HSHS (Hospital Sisters Health System) – Multiple HospitalscoreStrategic or Co-development PartnerCCSI partners with multiple HSHS hospitals to provide oncology services: HSHS St. Elizabeth's Hospital (O'Fallon), HSHS Holy Family Hospital (Greenville), HSHS St. Joseph's Hospital (Breese and Highland), HSHS St. Mary's Hospital (Decatur), and HSHS Good Shepherd Hospital (Shelbyville).
• Sparta Community HospitalcoreChannel Partner/ Reseller/ DistributorCCSI opened a Cancer Care Center in partnership with Sparta Community Hospital at the Broadway Plaza Specialty Clinic. Dr. Mark Walshauser provides oncology services at this location.
• KerbyStrong FoundationminorGTM or Marketing PartnerPartnership with KerbyStrong Foundation to raise funds for local cancer patients through events like the KerbySTRONG 100 auto race at Macon Speedway. CCSI sponsors the event annually.

Scale indicators7 records

Recent moves11 records

Expansion highlights6 records

Broad incumbents

• The US Oncology Network (McKesson): Largest U.S. network of community oncology practices with shared services, technology platforms, and drug-distribution economics. A major competitor in any metro market where CCSI seeks expansion.
• OneOncology: National platform partnering with independent community oncology practices. Represents the consolidator model CCSI competes against for physician talent, pharma contracting leverage, and value-based care infrastructure.

Direct peers

• Illinois CancerCare: Independent community oncology and hematology practice serving Central and Northern Illinois. Most direct regional competitor to CCSI, with a comparable multi-site model, clinical trial participation, and infusion/diagnostic service mix.
• Tennessee Oncology: Large multi-site community oncology and hematology practice in the Southeast with research affiliations and value-based care participation. A useful analog for CCSI's size, scope, and academic-network partnerships.
• Springfield Clinic: Large independent multi-specialty physician group serving Central Illinois with oncology services. Competes for the same patient referral base and primary-care referral network in overlapping geographies.
• Alliance Cancer Specialists: Community oncology practice operating across multiple sites with clinical-trial participation. Comparable in scale, multi-site delivery model, and value-based care positioning to CCSI.

Regional players

• Sarah Bush Lincoln Health System: Regional health system and hospital partner of CCSI in Mattoon/Effingham. Represents the embedded-hospital model and the partner that could in theory insource oncology services if the partnership dissolved.
• Carle Health: Regional integrated health system operating in Central Illinois (Carle Richland Memorial in Olney is a CCSI host site). Comparable as a regional provider with employed-physician oncology capabilities.
• Hospital Sisters Health System (HSHS): Multi-state Catholic hospital system hosting multiple CCSI clinic locations across Illinois. A critical partnership counterparty whose strategic decisions directly affect CCSI's footprint.

Emerging players

• American Oncology Network (AON): Growing network of community oncology practices with shared services for revenue cycle, pharmacy, and clinical trials. Competes for affiliation of independent oncology groups and represents an alternative path to scale versus CCSI's standalone model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/CancerCareIL
• YouTubeyoutube.com/user/CCSCentralIL
• Facebookfacebook.com/ccsci
• LinkedInlinkedin.com/company/cancer-care-specialists-of-illinois
• Instagraminstagram.com/cancercarespecialists

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cancer Care Specialists of Illinois